.Pharmacolibrary.Drugs.V_Various.V09D_HepaticAndReticuloEndothelialSystem.V09DB02_Technetium99mtcMicrocoll.Technetium99mtcMicrocoll .Pharmacolibrary.Drugs.V_Various.V09D_HepaticAndReticuloEndothelialSystem.V09DB02_Technetium99mtcMicrocoll.Technetium99mtcMicrocoll| name: | Technetium99mtcMicrocolloid | |
| ATC code: | V09DB02 | |
| route: | subcutaneous | |
| compartments: | 1 | |
| dosage: | 0.2 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Technetium (99mTc) microcolloid is a radiopharmaceutical used primarily for imaging in nuclear medicine. It is most commonly applied in sentinel lymph node mapping, liver-spleen scintigraphy, and bone marrow imaging. It is an approved and widely used diagnostic agent today.
No detailed pharmacokinetic studies (e.g., model-based PK parameters) have been published for technetium (99mTc) microcolloid in humans. Absorption/distribution are based on intended imaging organ after intravenous or subcutaneous administration, and elimination mainly occurs via the reticuloendothelial system and subsequent excretion.